fda warning peptides bpc-157 not approved safety concerns Public advisory FDA Compliance for Peptide Therapy

The compounds selective mechanism and lack of off-target effects support its safety profile

Rebooting this cycle is demanding

Absorption problems Even with adequate intake, absorption can be reduced by: Certain gastrointestinal conditions affecting the stomach or small intestine Some medications Age-related reduction in stomach acid (which can affect absorption) Autoimmune gastritis (often historically referred to as pernicious anaemia) This is a well-recognised cause of B12 deficiency and may require ongoing management

Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols